HIPAY GROUP SA (ALHYP.PA) Fundamental Analysis & Valuation

EPA:ALHYP • FR0012821916

Current stock price

5.8 EUR
+0.06 (+1.05%)
Last:

This ALHYP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALHYP.PA Profitability Analysis

1.1 Basic Checks

  • ALHYP had positive earnings in the past year.
  • In the past year ALHYP had a positive cash flow from operations.
  • In multiple years ALHYP reported negative net income over the last 5 years.
  • In the past 5 years ALHYP always reported a positive cash flow from operatings.
ALHYP.PA Yearly Net Income VS EBIT VS OCF VS FCFALHYP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M

1.2 Ratios

  • With a Return On Assets value of 2.61%, ALHYP perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
  • With a decent Return On Equity value of 13.62%, ALHYP is doing good in the industry, outperforming 71.15% of the companies in the same industry.
  • ALHYP has a Return On Invested Capital of 5.74%. This is in the better half of the industry: ALHYP outperforms 69.23% of its industry peers.
Industry RankSector Rank
ROA 2.61%
ROE 13.62%
ROIC 5.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALHYP.PA Yearly ROA, ROE, ROICALHYP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • The Profit Margin of ALHYP (7.88%) is comparable to the rest of the industry.
  • ALHYP has a Operating Margin of 6.71%. This is comparable to the rest of the industry: ALHYP outperforms 42.31% of its industry peers.
  • With a Gross Margin value of 49.04%, ALHYP perfoms like the industry average, outperforming 55.77% of the companies in the same industry.
  • ALHYP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.71%
PM (TTM) 7.88%
GM 49.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5Y1.7%
ALHYP.PA Yearly Profit, Operating, Gross MarginsALHYP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

3

2. ALHYP.PA Health Analysis

2.1 Basic Checks

  • ALHYP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for ALHYP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALHYP.PA Yearly Shares OutstandingALHYP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
ALHYP.PA Yearly Total Debt VS Total AssetsALHYP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ALHYP has an Altman-Z score of 0.36. This is a bad value and indicates that ALHYP is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.36, ALHYP is not doing good in the industry: 67.31% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.41 indicates that ALHYP is not too dependend on debt financing.
  • ALHYP has a Debt to Equity ratio (0.41) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACC0.54
WACC10.54%
ALHYP.PA Yearly LT Debt VS Equity VS FCFALHYP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that ALHYP should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.05, ALHYP is in line with its industry, outperforming 42.31% of the companies in the same industry.
  • A Quick Ratio of 1.05 indicates that ALHYP should not have too much problems paying its short term obligations.
  • ALHYP has a Quick ratio (1.05) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
ALHYP.PA Yearly Current Assets VS Current LiabilitesALHYP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

3

3. ALHYP.PA Growth Analysis

3.1 Past

  • The earnings per share for ALHYP have decreased strongly by -20.21% in the last year.
  • ALHYP shows a small growth in Revenue. In the last year, the Revenue has grown by 0.65%.
  • Measured over the past years, ALHYP shows a quite strong growth in Revenue. The Revenue has been growing by 10.34% on average per year.
EPS 1Y (TTM)-20.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%448.69%
Revenue 1Y (TTM)0.65%
Revenue growth 3Y8.26%
Revenue growth 5Y10.34%
Sales Q2Q%-2.21%

3.2 Future

  • Based on estimates for the next years, ALHYP will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.47% on average per year.
  • The Revenue is expected to grow by 3.93% on average over the next years.
EPS Next Y10.26%
EPS Next 2Y15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.01%
Revenue Next 2Y3.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALHYP.PA Yearly Revenue VS EstimatesALHYP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
ALHYP.PA Yearly EPS VS EstimatesALHYP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

5

4. ALHYP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.24, the valuation of ALHYP can be described as very cheap.
  • Based on the Price/Earnings ratio, ALHYP is valued cheaply inside the industry as 90.38% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.77. ALHYP is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 13.10, the valuation of ALHYP can be described as correct.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ALHYP.
  • ALHYP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.75, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.24
Fwd PE 13.1
ALHYP.PA Price Earnings VS Forward Price EarningsALHYP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALHYP is valued a bit cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.85
ALHYP.PA Per share dataALHYP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALHYP's earnings are expected to grow with 15.47% in the coming years.
PEG (NY)0.61
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3YN/A

0

5. ALHYP.PA Dividend Analysis

5.1 Amount

  • No dividends for ALHYP!.
Industry RankSector Rank
Dividend Yield 0%

ALHYP.PA Fundamentals: All Metrics, Ratios and Statistics

HIPAY GROUP SA

EPA:ALHYP (4/30/2026, 7:00:00 PM)

5.8

+0.06 (+1.05%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Industry Strength6.08
Industry Growth11.33
Earnings (Last)04-08
Earnings (Next)05-13
Inst Owners0.45%
Inst Owner ChangeN/A
Ins Owners50.11%
Ins Owner ChangeN/A
Market Cap36.60M
Revenue(TTM)74.78M
Net Income(TTM)5.89M
Analysts84.44
Price Target17.34 (198.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-35.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.47%
Valuation
Industry RankSector Rank
PE 6.24
Fwd PE 13.1
P/S 0.49
P/FCF N/A
P/OCF 5.89
P/B 0.85
P/tB N/A
EV/EBITDA 5.85
EPS(TTM)0.93
EY16.03%
EPS(NY)0.44
Fwd EY7.64%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.98
OCFY16.98%
SpS11.85
BVpS6.86
TBVpS-0.98
PEG (NY)0.61
PEG (5Y)N/A
Graham Number11.9781 (106.52%)
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 13.62%
ROCE 7.81%
ROIC 5.74%
ROICexc 7.65%
ROICexgc N/A
OM 6.71%
PM (TTM) 7.88%
GM 49.04%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5Y1.7%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA 2.02
Cap/Depr 169.65%
Cap/Sales 8.69%
Interest Coverage 1.58
Cash Conversion 70.2%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 0.36
F-Score4
WACC10.54%
ROIC/WACC0.54
Cap/Depr(3y)102.56%
Cap/Depr(5y)111.15%
Cap/Sales(3y)6%
Cap/Sales(5y)6.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%448.69%
EPS Next Y10.26%
EPS Next 2Y15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.65%
Revenue growth 3Y8.26%
Revenue growth 5Y10.34%
Sales Q2Q%-2.21%
Revenue Next Year4.01%
Revenue Next 2Y3.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-106.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.88%
OCF growth 3Y52.41%
OCF growth 5YN/A

HIPAY GROUP SA / ALHYP.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HIPAY GROUP SA (ALHYP.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALHYP.PA.


What is the valuation status for ALHYP stock?

ChartMill assigns a valuation rating of 5 / 10 to HIPAY GROUP SA (ALHYP.PA). This can be considered as Fairly Valued.


How profitable is HIPAY GROUP SA (ALHYP.PA) stock?

HIPAY GROUP SA (ALHYP.PA) has a profitability rating of 4 / 10.


Can you provide the financial health for ALHYP stock?

The financial health rating of HIPAY GROUP SA (ALHYP.PA) is 3 / 10.